DiaSorin S.p.A.

DiaSorin provides research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits globally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens.

Additionally, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay, as well as xMAP technology platform, including in vitro diagnostics. Founded in 1968, the company is headquartered in Saluggia, Italy.